GlassScriptPrepare for your visit
Babak Etemad
Gastroenterology (Internal Medicine) · Wynnewood, PA · NPI 1942268057
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$47,871.57
in general payments reported to CMS, 2019-2025 · $159 in 2025
The $159 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $41,187.58
- Olympus America INC. $6,217.48
- Janssen Scientific Affairs, LLC $96.65
- Cook Medical LLC $95.10
- Conmed Corporation $79.49
- Nestle Healthcare Nutrition INC. $60.03
Drugs and devices associated with these payments
Conmed Biliary Hemospray Skyrizi Rinvoq Hanarostent Esophagus Tts(Ccc)
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Babak Etemad listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/179176/babak-etemad